Other OTC - Delayed Quote USD

THC Therapeutics, Inc. (THCT)

0.0032 0.0000 (0.00%)
At close: April 19 at 2:40 PM EDT
Loading Chart for THCT
DELL
  • Previous Close 0.0032
  • Open 0.0032
  • Bid --
  • Ask --
  • Day's Range 0.0032 - 0.0032
  • 52 Week Range 0.0001 - 0.0078
  • Volume 7,500
  • Avg. Volume 679
  • Market Cap (intraday) 109,267
  • Beta (5Y Monthly) 103.31
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Feb 26, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

THC Therapeutics, Inc. operates in the wellness industry. It engages in the developing of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested cannabis, other herbs, flowers, and tea leaves. The company was formerly known as Millennium Blockchain, Inc. and changed its name to THC Therapeutics, Inc. in September 2018. THC Therapeutics, Inc. was founded in 2007 and is based in Las Vegas, Nevada.

thct.io

1

Full Time Employees

July 31

Fiscal Year Ends

Related News

Performance Overview: THCT

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

THCT
3,100.00%
S&P 500
5.84%

1-Year Return

THCT
23.08%
S&P 500
22.03%

3-Year Return

THCT
98.55%
S&P 500
20.77%

5-Year Return

THCT
99.97%
S&P 500
72.46%

Compare To: THCT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: THCT

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    109.27k

  • Enterprise Value

    841.27k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -2.75

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -280.77%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -387.04k

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -69.98k

Company Insights: THCT

People Also Watch